isoglutamine
{{chembox
| verifiedrevid = 443890865
| ImageFile1 = S-Isoglutamine skeletal.svg
| ImageName1 = (S/L)-Isoglutamine
| ImageFile2 = R-Isoglutamine skeletal.svg
| ImageName2 = (R/D)-Isoglutamine
| IUPACName = α-Glutamine
| OtherNames =
| SystematicName = 4,5-Diamino-5-oxopentanoic acid
| Section1 = {{Chembox Identifiers
| Abbreviations = IsoGln
| index_label=DL
| index2_label=(S/L)
| index3_label=(R/D)
| InChI1 = 1/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)
| InChIKey1 = AEFLONBTGZFSGQ-UHFFFAOYAS
| CASNo_Ref = {{cascite|correct|CAS}}
| CASNo = 328-48-3
| CASNo2_Ref = {{cascite|correct|CAS}}
| CASNo2 = 636-65-7
| CASNo3_Ref = {{cascite|correct|CAS}}
| CASNo3 = 19522-40-8
| DrugBank2 = DB03091
| DTXSID3 = DTXSID90415341
| KEGG = C16673
| PubChem = 164697
| PubChem2 = 445883
| PubChem3 = 5288447
| UNII = 00VZE9Y4WF
| UNII2 = WL74QNU57B
| UNII3 = IY2O406N69
| InChI= 1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 144380
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = AEFLONBTGZFSGQ-UHFFFAOYSA-N
| InChI2=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m0/s1
| InChIKey2 = AEFLONBTGZFSGQ-VKHMYHEASA-N
| InChI3=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m1/s1
| InChIKey3 = AEFLONBTGZFSGQ-GSVOUGTGSA-N
| SMILES = O=C(N)C(N)CCC(=O)O
| SMILES2 = C(CC(=O)O)[C@@H](C(=O)N)N
| SMILES3 = C(CC(=O)O)[C@H](C(=O)N)N
}}
| Section2 = {{Chembox Properties
| Properties_ref =
| C=5 | H=10 | N=2 | O=3
| Appearance =
| Density =
| MeltingPt =
| Solubility =
| SpecRotation =
}}
}}
Isoglutamine or α-glutamine is a gamma amino acid derived from glutamic acid by substituting the carboxyl group in position 1 with an amide group.{{Cite web |url=https://www.drugs.com/dict/isoglutamine.html |title=Drugs.com: Isoglutamine |access-date=2018-01-23 |archive-date=2018-09-20 |archive-url=https://web.archive.org/web/20180920172543/https://www.drugs.com/dict/isoglutamine.html |url-status=dead }} This is in contrast to the proteinogenic amino acid glutamine, which is the 5-amide of glutamic acid.
Isoglutamine can form the C-terminus of a peptide chain, as in muramyl dipeptide (MDP), a constituent of bacterial cell walls. It can also occur inside a peptide chain, in which case the chain is continued at the carboxyl group and isoglutamine behaves as a γ-amino acid, as in mifamurtide, a synthetic derivative of MDP used to treat osteosarcoma.
Stereochemistry
Substituting {{sm|l}}-glutamic acid, the proteinogenic enantiomer, gives {{sm|l}}-isoglutamine, which has S configuration. {{sm|d}}-Isoglutamine, the derivative of the nonproteinogenic {{sm|d}}-glutamic acid, has R configuration.{{cite journal|last1=Brundish|first1=D. E.|last2=Wade|first2=R.|title=Synthesis of N-[2-3H]acetyl-D-muramyl-L-alanyl-D-iso-glutaminyl-L-alanyl-2-(1',2'-dipalmitoyl-sn-glycero-3'-phosphoryl)ethylamide of high specific radioactivity|journal=J Label Compd Radiopharm|volume=22|issue=1|year=1985|pages=29–35|doi=10.1002/jlcr.2580220105}} The latter is the form occurring in MDP and mifamurtide.
References
{{reflist}}